Avant Technologies enters $20M equity financing agreement with GHS Investments at 80% discount

AVAI BIO, INC.

Up to $20M of common stock over 24 months; purchase price is 80% of lowest traded price in prior 10 trading days.
After NASDAQ uplist, price becomes 90% of lowest VWAP with $0.50 floor; puts capped at $500K each.
Company can initiate puts only when registration effective; GHS ownership limited to 4.99% of outstanding shares.
First closing requires $8,000 deposit to investor's legal counsel for transaction costs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.